Axisresearch
List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
Sorted by Name
Publishers
Countries
Microfluidics Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 07-06-2019
Market Overview
The global microfluidics market was valued at USD 4,748.18 million in 2018, and is estimated to be valued at USD 13,348.29 million in 2024, witnessing a CAGR of 18.80%. Factors that are propelling the growth of the market include rising demand for point-of-care testing, increasing Incidences of chronic diseases, faster turn-around time for analysis, and improved portability of devices.
POC testing allows healthcare experts to diagnose a patient in the physician’s office, in an ambulance, at home, field, or in the hospital. Microfluidic technology-assisted devices are being employed for POC testing, as they require small volumes of samples and use micro-fabricated channels to analyze these samples. POC testing devices are already popular in glucose, blood, hemoglobin, and HIV testing domains. Future POC testing devices are likely to focus more on antibiotics therapies and cancer.
With the wide range of applications offered by these devices, microfluidic technology-based POC testing devices have immense potential in the developing and developed countries, as the percentage of population affected by these diseases is high.
Scope of the Report
This report estimates the global microfluidics market size by summing up the value of market segments divided on the basis of type of component, application, and materials. Further, each of these segments are sub-divided to cover all relevant categories.
Key Market Trends
Clinical Diagnostics is Expected to hold its Highest Market Share in the Application Segment
In the application segment of the microfluidics market, clinical diagnostics is believed to have the largest market size and is expected to witness a CAGR of 18.80% during the forecast period.
A significant application area for microfluidic technology is clinical diagnostics. Specifically for clinical diagnostics, diseases, including toxicity, can be diagnosed by performing various biochemical analyzes and by observation of symptoms. The biochemical changes in the patient’s blood can signal organ damage or dysfunction, prior to observable microscopic cellular damages or other symptoms.
So there has been a large demand for the development of an easy-to-handle and inexpensive clinical diagnostic biochip using fully integrated plastic microfluidic chips, which have the sampling/identifying capability of fast and reliable measurements of metabolic parameters from a human body with minimum invasion. Thus, the growth of clinical diagnostics is expected to fuel the market’s growth.
North America Dominates the Market and is Expected to do the Same in the Forecast Period
The North American region holds the largest market share in the market for microfluidics. This is attributed to factors, such as the well-established healthcare system, along with better reimbursement policies, and the higher adoption of novel therapeutics among the general population. Microfluidics is a vastly growing field in the United States, in terms of high budget sanctions for R&D. Molecular diagnostics and point-of-care diagnostics widely use microfluidic technology for various applications, and hence, they occupy a major market share in the United States. Owing to this, the United States has the largest market share of 88% in North America, and is expected to grow at a rate of 18.8% over the forecast period.
Competitive Landscape
The microfluidics market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new technologies with affordable prices. Companies, like Danaher Corporation, PerkinElmer Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., and Thermo Fisher Scientific Inc., hold substantial shares in the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Demand for Point-of-care Testing
4.2.2 Increasing Incidences of Chronic Diseases
4.2.3 Faster Turn-around Time for Analysis and Improved Portability of Devices
4.3 Market Restraints
4.3.1 Need for Specialized Skills in Operations and Complex Regulatory Approval Process
4.3.2 Low Adoption in Developing Countries due to High Prices
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Component
5.1.1 Microfluidic Chips
5.1.2 Micro Pumps
5.1.3 Micro Needles
5.1.4 Other Components
5.2 Application
5.2.1 Drug Delivery
5.2.2 High-throughput Screening
5.2.3 Point-of-Care Diagnostics
5.2.4 Lab Analytics
5.2.4.1 Proteomics
5.2.4.2 Genomics
5.2.4.3 Cell-based Assay
5.2.4.4 Capillary Electrophoresis
5.2.5 Clinical Diagnostics
5.3 Material
5.3.1 Polymer
5.3.2 Silicone
5.3.3 Glass
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 F. Hoffmann-LA Roche Ltd
6.1.3 Agilent Technologies
6.1.4 Danaher Corporation (Cepheid)
6.1.5 Thermo Fisher Scientific Inc.
6.1.6 Bio-Rad Laboratories Inc.
6.1.7 PerkinElmer Inc.
6.1.8 FluIdigm Corporation
6.1.9 Dolomite Microfluidics (Blacktrace Holdings Ltd)
6.1.10 Micronit Microfluidics
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Component
Microfluidic Chips
Micro Pumps
Micro Needles
Other Components
Application
Drug Delivery
High-throughput Screening
Point-of-Care Diagnostics
Lab Analytics
Proteomics
Genomics
Cell-based Assay
Capillary Electrophoresis
Clinical Diagnostics
Material
Polymer
Silicone
Glass
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Microbiology Testing Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 110 pages | Published: 13-06-2019 |
- Healthcare
- Mordor Intelligence
- 110 pages
- Published: 13-06-2019
Market Overview
The propelling factors for the growth of the microbiology testing market include technological advancements in microbiology testing, rising incidences of infectious diseases and outbreak of epidemics, growing healthcare expenditure, and rising private-public funding for research on infectious diseases.
Infectious diseases, such as HIV, human papilloma virus (HPV), and hepatitis B and C, are some forms of STDs that are severe and fatal, and thus the increasing incidences of such diseases are increasing the demand for the microbiology testing market. Increasing healthcare expenditure and the presence of better medical infrastructures, such as hospitals and clinical labs, are some other drivers augmenting the growth of the microbiology testing market.
Rapid growth observed in the geriatric population, increasing number of clinical researches in the field of clinical microbiology, rising incidences of infectious diseases, and increased funding, research grants, and public-private investments are some of the factors that are driving the microbiology testing market.
Rapid technological advancements are also being witnessed across the world that are anticipated to drive the microbiology testing market in the upcoming years. There are emerging economies, such as India and China, which may offer new growth opportunities for the microbiology testing market over the forecast period.
Scope of the Report
As per the scope of the report, microbial testing is an analytical technique that is utilized to determine the number of microorganisms in food, beverages, biological samples, and environmental samples. The microbial testing technique employs chemical, biological, biochemical, or molecular methods to identify and quantify the microbes. It is one of the important processes carried out in medical, healthcare, and food industries for the prevention of future product damages.
Key Market Trends
Diagnostic Holds the Largest Revenue Share in the Applications and is Expected to do Same
The diagnostics segment is expected to account for the largest share of the microbiology testing market. Some of the key factors driving the growth of this segment are the increasing prevalence of infectious diseases, improving healthcare expenditure, and technological advancements.
The pharmaceutical application segment is also expected to dominate due to the presence of well-established and globally accepted regulations, which govern the evaluation of microbial contamination during pharmaceutical manufacturing and raw material sourcing processes.
Europe Holds the Fastest Growth and is Expected to Follow the Same Trend Over the Forecast Period
The European region is expected to show the fastest growth for microbiology testing and is anticipated to contribute notably toward the microbiology testing market over the forecast period. These can be attributed to the presence of advanced healthcare infrastructure in the region, along with various technological advancements witnessed in this region’s healthcare industry.
However, Asia-Pacific is also expected to grow in the upcoming future, due to the expanding R&D and innovative microbiology testing procedures and the increasing number of hospitals and testing laboratories.
Competitive Landscape
The microbiology testing market has witnessed new product launches, mergers and acquisitions, partnerships, joint ventures, and strategies adopted by the major players to gain competitive advantage. The companies are also introducing advanced microbiological automated systems that have high throughputs and are less time-consuming.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Technological Advancements in Microbiology Testing
4.2.2 Rising Incidences of Infectious Diseases and Outbreak of Epidemics
4.2.3 Growing Healthcare Expenditure
4.2.4 Rising Private-Public Funding for Research on Infectious Diseases
4.3 Market Restraints
4.3.1 Laboratory Reimbursement Issues
4.3.2 High Cost of Microbiology Instruments
4.4 Porters Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Application
5.1.1 Pharmaceutical Application
5.1.2 Diagnostic Application
5.1.3 Food and Beverage Testing Application
5.1.4 Environmental Application
5.1.5 Cosmetic Application
5.1.6 Other Applications
5.2 By Product
5.2.1 Equipment
5.2.2 Reagent
5.3 Geography
5.3.1 North America
5.3.1.1 US
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 UK
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bio-Rad Laboratories Inc.
6.1.2 Abbott Laboratories
6.1.3 Becton Dickinson and Company
6.1.4 F. Hoffmann-La Roche Ltd
6.1.5 Bruker Corporation
6.1.6 Hologic Corporation
6.1.7 Cepheid Inc.
6.1.8 Biomerieux SA
6.1.9 Thermo Fisher Scientific Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Application
Pharmaceutical Application
Diagnostic Application
Food and Beverage Testing Application
Environmental Application
Cosmetic Application
Other Applications
By Product
Equipment
Reagent
Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Mexico General Surgical Devices Market – Growth, Trends, and Forecasts (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 74 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 74 pages
- Published: 07-06-2019
Market Overview
The Mexican general surgical devices market is expected to record a CAGR of around 4.8% over the forecast period, 2019-2024. Certain factors that are accelerating the growth of the market include rising demand for minimally invasive devices, technological advancements in general surgical devices, and rising unmet healthcare needs in the country, along with the rising expenditure on health.
This rise in healthcare expenditure is anticipated to accelerate medical infrastructural development, which is likely to fuel the growth of the surgical devices market in Mexico. Major manufacturers of surgical devices are focusing on gaining a foothold in emerging economies, such as Brazil and Mexico, in order to expand their business operations and explore new markets, thus creating an advanced healthcare infrastructure. Thus, increasing healthcare expenditure, strong local manufacturing base, and rapidly developing healthcare infrastructure, have led to increased and advanced surgical procedures performed in this country. Hence, these factors are likely to offer immense growth opportunities in the Mexican surgical procedures market.
Scope of the Report
The general surgical devices are specially designed tools or instruments that serve a specific purpose during a surgery, which include scissors, forceps, surgical needles, etc.
Key Market Trends
Handheld Devices Segment by Product is Expected to Record the Highest CAGR over the Forecast Period
The handheld devices segment of the Mexican general surgical devices market is expected to register the highest CAGR over the forecast period.
The demand for surgical equipment is increasing in response to the rising need for minimally invasive surgeries in the country. Handheld surgical devices are becoming increasingly advanced. The large-scale use of advanced surgical instruments in recent years is driving the handheld devices segment in Mexico. The development of advanced tools, like robotic hand-held surgical devices for laparoscopic interventions, enhances a surgeon’s ability. Many innovations have been made owing to the need for high reliability, accuracy, and patient safety. Therefore, there is an increasing demand for handheld devices, which in turn, is helping the segment to grow faster.
Competitive Landscape
Some of the major companies in the Mexican general surgical devices market are B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Medtronic PLC, and Stryker Corporation. Along with these big players, the market is also witnessing some of the smaller players that hold a substantial market share.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1. Introduction
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand for Minimally Invasive Devices
4.2.2 Technological Advancements in General Surgical Devices
4.2.3 Rising Unmet Healthcare Needs
4.2.4 Rising Health Expenditure
4.3 Market Restraints
4.3.1 High Capital Expenses Needed to Produce Surgical Equipment
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. Market Segmentation
5.1 By Product
5.1.1 Handheld Devices
5.1.2 Laproscopic Devices
5.1.3 Electro Surgical Devices
5.1.4 Wound Closure Devices
5.1.5 Trocars and Access Devices
5.1.6 Other Products
5.2 By Application
5.2.1 Gynecology and Urology
5.2.2 Cardiology
5.2.3 Orthopaedic
5.2.4 Neurology
5.2.5 Other Applications
6. Competitive Landscape
6.1 Company Profiles
6.1.1 B. Braun Melsungen AG
6.1.2 Boston Scientific Corporation
6.1.3 Conmed Corporation
6.1.4 Integer Holdings Corporation
6.1.5 Johnson & Johnson
6.1.6 Medtronic PLC
6.1.7 Stryker Corporation
7. Market Opportunities and Future Trends
By Product
Handheld Devices
Laproscopic Devices
Electro Surgical Devices
Wound Closure Devices
Trocars and Access Devices
Other Products
By Application
Gynecology and Urology
Cardiology
Orthopaedic
Neurology
Other Applications
Medical Tourism Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 115 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 115 pages
- Published: 07-06-2019
Market Overview
The global medical tourism market was valued at USD 16,761 million in 2018, and it is expected to reach USD 27,247.6 million by 2024, while registering a CAGR of 8.5% during the forecast period, 2019-2023. The factors associated with the growth of the market include higher treatment cost in developed countries, availability of the latest medical technologies, growing compliance on international quality standards, high quality of service, health insurance portability, and advertising and marketing of the medical tourism.
The cost of undergoing medical treatment in a developed country is very high. It is estimated that although the treatments are of reliable quality, the procedures tend to be on the expensive side. Along with this, the major healthcare products are also quite extravagantly priced. This scenario places a big burden on the healthcare systems, worldwide, accompanied by the additional rising costs of litigation during recent times. Healthcare practitioners need to be aware of both the direct and indirect costs and consider how the implementation of prevention protocols may offer cost savings in the longer term. People in developed countries cannot afford the huge expenditure associated with medical treatments. Not all medical bills are covered by insurance companies, which makes the patients turn to countries abroad. Countries in Asia, the Middle East, and South America provide high-quality medical services at a much lower rate, as compared to the developed economies. There are companies that cater to all the medical and non-medical needs of the tourist during their travel.
Scope of the Report
As per the scope of the report, medical tourism is an improvement of the healthcare system, which provides quality medical care to people seeking treatment. Patients travel to other countries for obtaining good medical treatment.
Key Market Trends
Fertility Treatments Segment Expected to Have Highest CAGR
The fertility treatments segment of the medical tourism market is believed to show the fastest growth over the forecast period. The segment is expected to record a CAGR of 9.7% over the forecast period. Fertility treatment is one of the most common treatments for which medical tourists elect to travel across international borders. Fertility tourism or reproductive tourism is one of the fastest-growing areas.
About 20,000 to 25,000 couples annually seek assisted reproductive technology services abroad. An estimated 4.0% of European Union citizens receive treatment in other countries. Fertility treatment procedures are regulated in most European countries.
Asia-Pacific Currently Dominates the Market
The Asia-Pacific region currently dominates the medical tourism market and it is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the raised preference of medical tourism across the developing countries of this region. China holds the majority of the market in the Asia-Pacific region. This is due to the lower cost of the treatment in China and the better healthcare services provided.
Competitive Landscape
The global medical tourism market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancement and quality service provision, mid-size to smaller companies are increasing their market presence by introducing new products with fewer prices. Companies, like Healthbase, Apollo Hospitals, KPJ Healthcare, and Klinikum Medical Link hold the significant market share in the medical tourism market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Treatment Cost in Developed Countries
4.2.2 Availability of Latest Medical Technologies
4.2.3 Growing Compliance on International Quality Standards
4.2.4 High Quality of Service
4.2.5 Health Insurance Portability
4.2.6 Advertising and Marketing
4.3 Market Restraints
4.3.1 Ethical Concerns
4.3.2 Epidemic Outbreaks
4.3.3 Issues with Patient Follow Up and Post-procedure Complications
4.3.4 Medical Record Transfer Issues
4.4 Industry Attractiveness of Porter’s Five Forces Analysis
5 MARKET SEGMENTATION
5.1 By Treatment Type
5.1.1 Cosmetic Treatment
5.1.2 Dental Treatment
5.1.3 Cardiovascular Treatment
5.1.4 Orthopedics Treatment
5.1.5 Bariatric Surgery
5.1.6 Fertility Treatment
5.1.7 Ophthalmic Treatment
5.1.8 Other Treatments
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 France
5.2.2.2 Germany
5.2.2.3 United Kingdom
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East & Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East & Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Medretreat
6.1.2 Healthbase
6.1.3 Apollo Hospitals
6.1.4 KPJ Healthcare Behard
6.1.5 Klinikum Medical Link
6.1.6 Euromedical Tours
6.1.7 BB Health Solutions
6.1.8 Cosmedic Travel
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Treatment Type
Cosmetic Treatment
Dental Treatment
Cardiovascular Treatment
Orthopedics Treatment
Bariatric Surgery
Fertility Treatment
Ophthalmic Treatment
Other Treatments
Geography
North America
United States
Canada
Mexico
Europe
France
Germany
United Kingdom
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Medical Simulation Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 07-06-2019
Market Overview
The propelling factors for the growth of the medical simulation market include continuous technological advancements, increasing concerns over patient safety, and increasing demand for minimally invasive treatments.
The requirement of medical simulation in minimally invasive surgery has been established over the past few years. The minimally invasive techniques are becoming the standards of surgical techniques, at a very fast pace, for a number of surgical procedures. These MIS procedures involve smaller incisions leading to quicker recovery, which helps in the growth of the overall market.
The use of medical simulation devices, along with standardized patient simulators, has gained rapid growth over the last few years, mainly due to increasing technological advancements and their adoption in the field of healthcare. The barriers to adopting simulation products and services in hospitals include lack of funding, less time for simulation exercises, release from job environment, lack of management interest, etc.
The METIman simulator is found to be one of the most advanced and realistic simulators in the recent times, developed by the CAE simulators. Thus, the rise in various technological advancements in the field of medical simulation is increasing the applications in healthcare to train healthcare professionals, and as a result of which, the growth of the market studied is expected to propel over the forecast period.
Scope of the Report
As per the scope of the report, medical simulation is the modern day methodology for training healthcare professionals through the use of advanced educational technology. Medical simulation is experiential learning that every healthcare professional may need, but cannot be always engaged in during real-life patient care. The market of medical stimulation is growing with increasing healthcare facilities.
Key Market Trends
Laparoscopic Surgical Simulators is the Segment under Interventional/Surgical Simulators that is Expected to Grow the Fastest during the Forecast Period
Surgeons are found shifting to MIS, primarily laparoscopy and robotic surgery from open surgery. However, the MIS, primarily laparoscopy and robotic surgery, requires skilled surgeons to deliver successful procedures. There has been a rapid adoption of the MIS in the cholecystectomy, appendectomy, gastric bypass, ventral hernia repair, colectomy, prostatectomy,tubal ligation, hysterectomy, and myomectomy procedures. Thus, the increasing MIS surgeries and the need for skilled professionals have propelled the laparoscopic surgical simulators market.
There are also cardiac surgeries that have been a major challenge for surgeons because of the complex nature of the surgery and the need for highly skilled professionals. Also, there has been a change observed in general surgery training, with the shift from open surgery toward the endovascular and minimally invasive approaches to disease management. Therefore, further simulation is expected to reduce the risks associated with the complex operations of cardiothoracic surgery and help create a more efficient, thorough, and uniform curriculum for cardiothoracic surgery fellowships.
Asia-Pacific Registered the Fastest Growth and is Expected to follow the Same Trend over the Forecast Period
Asia-Pacific is projected to exhibit the fastest growth, due to the increasing demand for healthcare simulation and its related services. The emerging economies of India and China are expected to majorly boost the market, due to the growing thrust on medical studies and research. In addition, the ease of doing business in Asian countries is high, due to the availability of high labor and low manufacturing cost. This is an important factor that is estimated to augment the market in Asia-Pacific.
Competitive Landscape
The market is highly fragmented with many players. With many small and medium players, the competition is high. The market has been experiencing the entry of new players over the last few years, owing to the rising popularity of simulation technology. The existing players are differentiating on the basis of price, quality, and technology.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Continuous Technological Advancements
4.2.2 Increasing Concerns over Patient Safety
4.2.3 Increasing Demand for Minimally Invasive Treatments
4.3 Market Restraints
4.3.1 High Cost of Simulators
4.3.2 Reluctance to Adopt New Training Methods
4.3.3 Limited Availability of Funds, Especially in the Developing and Underdeveloped Countries
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Products and Services
5.1.1 Products
5.1.1.1 Interventional/Surgical Simulators
5.1.1.1.1 Laparoscopic Surgical Simulators
5.1.1.1.2 Gynecology Surgical Simulators
5.1.1.1.3 Cardiac Surgical Simulators
5.1.1.1.4 Arthroscopic Surgical Simulators
5.1.1.1.5 Other Products
5.1.1.2 Task Trainers
5.1.1.3 Other Products and Services
5.1.2 Services and Software
5.1.2.1 Web-based Simulation
5.1.2.2 Medical Simulation Software
5.1.2.3 Simulation Training Services
5.1.2.4 Other Services and Software
5.2 By Technology
5.2.1 High-fidelity Simulators
5.2.2 Medium-fidelity Simulators
5.2.3 Low-fidelity Simulators
5.3 By End User
5.3.1 Academic and Research Institutes
5.3.2 Hospitals
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 3D Systems
6.1.2 Canadian Aviation Electronics (CAE)
6.1.3 Gaumard Scientific Company Inc.
6.1.4 Kyoto Kagaku Co. Ltd
6.1.5 Laerdal Medical
6.1.6 Limbs & Things Ltd
6.1.7 Mentice AB
6.1.8 Simulab Corporation
6.1.9 Simulaids Inc.
6.1.10 Nasco
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Products and Services
Products
Interventional/Surgical Simulators
Laparoscopic Surgical Simulators
Gynecology Surgical Simulators
Cardiac Surgical Simulators
Arthroscopic Surgical Simulators
Other Products
Task Trainers
Other Products and Services
Services and Software
Web-based Simulation
Medical Simulation Software
Simulation Training Services
Other Services and Software
By Technology
High-fidelity Simulators
Medium-fidelity Simulators
Low-fidelity Simulators
By End User
Academic and Research Institutes
Hospitals
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Medical Marijuana Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 07-06-2019
Market Overview
The major factors for the growth of the medical marijuana market include the increasing number of countries legalizing the use of medical marijuana, trend of producing edible products with cannabis, and favorable reimbursement environment and government support in selected countries, which are expected to experience a boost over the forecast period.
Each year, the legal use of cannabis for medical and recreational purposes is steadily growing, but it varies across countries, based on the possession, distribution, cultivation, and medical indications for its consumption. Therefore, over the forecast period, the change is expected to be slow, but more legal consumption of cannabis is expected in the developed market, which is expected to largely drive the market studied.
Currently, there is also an increasing use of marijuana as a functional food, with purported health benefits far outnumbering what consumers can get from kale, turmeric, or kombucha. With the new generation growing up in the United States, where cannabis is legal, new products are found rapidly entering the market, which is expected to grow rapidly over the forecast period. The growth of the market is also attributed to factors, like the trends of producing edible products with cannabis in selected countries. Therefore marijuana is expected to be included in the 2018 food trends, as the drug and its ingredients have been gradually making their way into the public market.
Doctors also prescribe medical marijuana to treat muscle spasms caused by multiple sclerosis, nausea, poor appetite, and weight loss, caused by chronic illness, such as HIV, nerve pain, and Crohn’s disease. Thus, with the increasing applications, there is a huge opportunity for marijuana for medicinal purposes as well.
Scope of the Report
As per the scope of the report, medical marijuana refers to the whole, unprocessed marijuana plant, or its basic extracts, for the treatment of several diseases and other related symptoms. Scientific studies show that chemical cannabinoids could help treat a range of diseases and symptoms, which has attracted several biopharmaceutical companies, globally, over the past two decades. The market is expected to witness significant growth, owing to legalization in several countries and high demand for both medical and recreational purposes.
Key Market Trends
Chronic Pain is the Segment under Application that is Expected to Experience the Fastest Growth during the Forecast Period
There are many studies that have shown that medical cannabis is found to be an effective method for the treatment of chronic pain, and that it is far safer than many other options. It is an affordable, natural alternative that lacks side effects and is traditionally used to treat chronic pain. There are also several ongoing researches on medical marijuana for the treatment of chronic pain, which is expected to directly impact the growth of the market.
Marijuana is also being used for the treatment of arthritis, as it has the potential to reduce inflammation, as well reduce pain. There is also an increasing research on medical marijuana for the treatment of cancer and commercially available cannabinoids, which are approved drugs for chemotherapy, and which are likely to augment the growth of the market. Marijuana, being an effective treatment for neuropathic pain, is expected to further rise over the forecast timeframe.
North America Accounted for the Largest Share in the Global Market
North America holds the major share in the medical marijuana market, and is expected to show a similar trend over the forecast period, without significant fluctuations. The surging pace of cannabis legalization in the United States is one of the key factors contributing to its increased demand. There are also many marijuana programs in the United States that have accelerated, and most of the states have started to approach medical marijuana from the perspective of good public health.
Competitive Landscape
The market studied is dominated by a few major players, and currently, only in a few countries, the use of cannabis is legal. Because of this, several companies were not able to launch their products.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Number of Countries Legalizing the Use of Medical Marijuana
4.2.2 Trend of Producing Edible Products with Cannabis
4.2.3 Favorable Reimbursement Environment and Government Support in Certain Countries
4.3 Market Restraints
4.3.1 Lack of Awareness about the Dosage and Medicinal Properties of Marijuana
4.3.2 Social Stigma Related to Cannabis Use
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Application
5.1.1 Chronic Pain
5.1.2 Arthritis
5.1.3 Migraine
5.1.4 Cancer
5.1.5 Other Applications
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East & Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East & Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Canopy Growth
6.1.2 Lexaria Corp.
6.1.3 United Cannabis Corporation
6.1.4 Aurora Cannabis
6.1.5 Cannabis Sativa Inc.
6.1.6 Cara Therapeutics Inc.
6.1.7 GW Pharmaceuticals PLC
6.1.8 LivWell Enlightened Health LLC
6.1.9 Aphria Inc
6.1.10 Medical Marijuana Inc.
6.1.11 Lexaria Corporation
6.1.12 United Cannabis Corporation
6.1.13 Aurora Cannabis
6.1.14 Cannabis Sativa Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Application
Chronic Pain
Arthritis
Migraine
Cancer
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America